Nut consumption may decrease risk of colorectal, endometrial cancers
the ONA take:
According to a systematic review published in the journal Nutrition Reviews, researchers at the May Clinic in Rochester and the University of Minnesota in Minneapolis, Minnesota, have found that nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.
For the study, researchers analyzed data from 36 observation studies that included 30,708 patients. Results showed that nut consumption was associated with a decreased risk for colorectal, endometrial, and pancreatic cancer.
Researchers did not find an association between nut consumption and a reduced risk for other types of cancer or type 2 diabetes.
"Our study suggests that nut consumption may be associated with reduced risk of cancers, which may have practical implication. Aligning with the known beneficial effect of nuts on heart diseases, our study may imply that individuals interested in making better food choices to reduce the risk of cancer and heart disease can consider consuming nuts, after considering the caloric and fat contents of different types of nuts", said Lang Wu, principal investigator of the study.
Nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- The Integration of Cannabis in Oncologic Care
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|